HOME >> BIOLOGY >> NEWS
Novel, even unlikely drugs may curb childhood leukemia

Philadelphia, Pa.While survival rates for childhood leukemias have soared in the past 30 years, about a quarter of pediatric cases remain stubbornly resistant to treatment. As a new attack strategy, scientists are adapting recent discoveries about cell development to coax leukemia cells back to normal growth patterns or to reprogram them into committing suicide.

"Reaching the next level of leukemia treatment will require many new approaches that draw upon our expanding knowledge about how healthy cells differentiate during normal growth and development," said Beverly Lange, M.D., director of experimental therapeutics within the Division of Oncology at The Childrens Hospital of Philadelphia, who is an expert in these new attack strategies.

Unlike conventional cancer drugs, the newer drugs are based on detailed knowledge of cellular mechanisms that can be used to manipulate cancer cells in a way that is gentler to surrounding healthy cells.

Oncologists at Childrens Hospital are investigating a number of novel, even unlikely, drugs as highly specific, less toxic weapons against childhood leukemia. For example:
-- A form of vitamin A is being used to reprogram a cancer cell into becoming a harmless, normal white blood cell.
-- Borrowing from its use in traditional Chinese medicine, carefully controlled doses of arsenic can trigger cancer cells to commit suicide by mimicking the normal developmental process of "apoptosis," or programmed cell death.
-- A new type of leukemia drug, the bioengineered compound Glivec, can block the genetic signals that direct cancer cells to grow, while leaving normal cells largely unharmed.
-- The naturally occurring protein interleukin-2 may kick-start the bodys immune system to better fight leukemia.

Taming cancer cells

Some experimental new treatments rely on methods that neutralize or disrupt cancer cells rather than killing them outright in a frontal attack. "Most conventional ca
'"/>

Contact: John Ascenzi
ascenzi@email.chop.edu
215-590-7332
Children's Hospital of Philadelphia
14-May-2001


Page: 1 2 3 4

Related biology news :

1. Goals unlikely to protect Gulf of Mexico shrimp industry
2. First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely
3. Sex selection for social reasons unlikely to skew gender balance in Germany and UK
4. An unlikely new weapon against a deadly bacteria in oysters: A virus
5. Suppressing entire immune system unlikely to be best way to treat autoimmune diseases, new findings show
6. Depressed heart attack survivors unlikely to change behavior
7. New model of staph drug resistance implicates unlikely protein
8. One in three physicians unlikely to get routine medical care
9. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
10. New and better drugs for tuberculosis goal of UH professor
11. New technique helps scientists reveal interactions between genes and drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/16/2018)... ... November 16, 2018 , ... Bergeson & Campbell, P.C. (B&C®) ... will engage listeners in intelligent, insightful conversation about everything related to industrial, pesticidal, ... team of lawyers, scientists, and consultants will keep listeners abreast of the changing ...
(Date:11/15/2018)... ... November 14, 2018 , ... Persivia, ... solutions, announced today that Prime Healthcare, a leading operator of over 50 hospitals ... , Persivia’s Bundled Payment solution consists of the industry’s only end to ...
(Date:11/13/2018)... ... November 13, 2018 , ... ... Retano will be a featured presenter at the upcoming CBI Gross-to-Net (GTN) Summit ... hospitality suite on Friday, November 16, where conference attendees will have the opportunity ...
Breaking Biology News(10 mins):
(Date:11/27/2018)... ... November 27, 2018 , ... New patients in need of a ... practice for treatment, with or without a referral. Dr. Myers has many years of ... veneers, dental implants, bridges and custom crowns. , As a dedicated cosmetic ...
(Date:11/20/2018)... ... , ... Each year Forbes receives thousands of nominations for candidates wishing to ... individuals under 30 years of age. The Forbes 30 Under 30 list showcases the ... Venture Capital and Science. , In 2017, Visikol CEO Dr. Michael Johnson was ...
(Date:11/13/2018)... ... November 12, 2018 , ... AseptiScope(TM), ... that two large U.S. studies, published last week, confirm pose a significant health ... Infection Control (AJIC) conclude that stethoscopes are often improperly or rarely disinfected. In ...
(Date:11/13/2018)... ... November 13, 2018 , ... Sharon Kleyne, founder ... in Grants Pass, Oregon believes in the power of talk radio education Power ... Science® sponsors the Power of Water® on talk radio every week with the ...
Breaking Biology Technology:
Cached News: